Immunohistochemical analysis demonstrated that the expression of IL-6 is increased in prostate cancer induced by intraprostatic injection of LNCaP cells stably transfected with SFMBT2 shRNA (Figure 6G). This evidence concerns the gene IL6 and Familial prostate cancer.